ArticleOncotarget2016

Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment.

Eric T Alexander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.